title: Notch signalling in cancer progression and bone metastasis.
abstract: Classically known for its indispensible role in embryonic development, the Notch signalling pathway is gaining recognition for its regulation of adult tissue homoeostasis and aberrant activation in disease pathogenesis. The pathway has been implicated in cancer initiation and development, as well as early stages of cancer progression by regulating conserved cellular programs such as the epithelial-to-mesenchymal transition. We recently extended the role of Notch signalling to late stages of tumour progression by elucidating a stroma-dependent mechanism for the pathway in osteolytic bone metastasis. Of clinical significance, disrupting the Notch pathway and associated molecular mediators of Notch-dependent bone metastasis may provide novel therapeutic strategies to combat aggressive bone metastatic disease.
authors.affiliation: Department of Molecular Biology, Princeton University, Washington Road, Princeton, NJ 08544, USA.
authors.forename: N
authors.initials: N
authors.lastname: Sethi
authors.forename: Y
authors.initials: Y
authors.lastname: Kang
mesh_terms: D001859:Bone Neoplasms / Q000556:secondary*; D018450:Disease Progression; D006801:Humans; D009362:Neoplasm Metastasis; D051880:Receptors, Notch / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D051880:Receptors, Notch
references.citation: Cancer Res. 2004 Oct 1;64(19):6854-7
references.pmid: 15466172
references.citation: Nature. 2010 May 6;465(7294):86-90
references.pmid: 20418862
references.citation: Bone. 2011 Jan;48(1):16-22
references.pmid: 20630490
references.citation: PLoS One. 2011;6(5):e20022
references.pmid: 21637838
references.citation: Science. 1999 Apr 30;284(5415):770-6
references.pmid: 10221902
references.citation: Int J Cancer. 2003 Feb 20;103(5):642-6
references.pmid: 12494472
references.citation: Cancer Res. 2002 May 15;62(10):2731-5
references.pmid: 12019144
references.citation: J Exp Med. 2007 Nov 26;204(12):2935-48
references.pmid: 17984306
references.citation: Cancer Cell. 2005 Jul;8(1):13-23
references.pmid: 16023595
references.citation: Cancer Res. 2004 Nov 1;64(21):7794-800
references.pmid: 15520185
references.citation: Oncogene. 1999 Oct 28;18(44):5973-81
references.pmid: 10557086
references.citation: J Biol Chem. 2010 Nov 5;285(45):34757-64
references.pmid: 20810660
references.citation: Genes Dev. 1992 Mar;6(3):345-55
references.pmid: 1372276
references.citation: J Exp Med. 1996 May 1;183(5):2283-91
references.pmid: 8642337
references.citation: Science. 2004 Oct 8;306(5694):269-71
references.pmid: 15472075
references.citation: Cancer Res. 2006 Feb 1;66(3):1517-25
references.pmid: 16452208
references.citation: Cancer Res. 2008 Nov 1;68(21):9087-95
references.pmid: 18974155
references.citation: Mol Cell Biol. 2008 Jun;28(11):3589-99
references.pmid: 18362162
references.citation: EMBO J. 2004 Mar 10;23(5):1155-65
references.pmid: 14976548
references.citation: Genes Dev. 2004 Jan 1;18(1):99-115
references.pmid: 14701881
references.citation: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8108-12
references.pmid: 9653148
references.citation: Cancer Cell. 2011 Feb 15;19(2):192-205
references.pmid: 21295524
references.citation: Eur J Cancer. 2006 Jul;42(11):1564-73
references.pmid: 16765041
references.citation: Nature. 2010 Dec 2;468(7324):637-8
references.pmid: 21124441
references.citation: J Cell Physiol. 2003 Mar;194(3):237-55
references.pmid: 12548545
references.citation: Oncogene. 2004 Dec 16;23(58):9401-7
references.pmid: 15531924
references.citation: Anticancer Res. 1999 Mar-Apr;19(2B):1427-32
references.pmid: 10365118
references.citation: Cell. 1991 Aug 23;66(4):649-61
references.pmid: 1831692
references.citation: J Clin Invest. 2008 Nov;118(11):3660-70
references.pmid: 18924608
references.citation: Neoplasma. 2007;54(4):304-10
references.pmid: 17822320
references.citation: Eur J Cancer. 2010 May;46(7):1232-40
references.pmid: 20307969
references.citation: Cell. 1991 Mar 22;64(6):1083-92
references.pmid: 2004417
references.citation: Curr Opin Genet Dev. 1994 Aug;4(4):556-62
references.pmid: 7950324
references.citation: Oncogene. 2008 Sep 1;27(38):5148-67
references.pmid: 18758484
references.citation: Cancer Res. 2009 Jan 1;69(1):329-37
references.pmid: 19118018
references.citation: Nat Med. 2002 Sep;8(9):979-86
references.pmid: 12185362
references.citation: Mol Cell. 2000 Feb;5(2):207-16
references.pmid: 10882063
references.citation: J Clin Invest. 2007 Dec;117(12):3988-4002
references.pmid: 18060036
references.citation: Nature. 1998 May 28;393(6683):382-6
references.pmid: 9620803
references.citation: J Natl Cancer Inst. 2000 Aug 16;92(16):1355-7
references.pmid: 10944559
references.citation: Nat Rev Urol. 2010 Sep;7(9):494-509
references.pmid: 20818327
references.citation: Cell. 2009 Apr 17;137(2):216-33
references.pmid: 19379690
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7638-43
references.pmid: 12794186
references.citation: Immunity. 1999 May;10(5):547-58
references.pmid: 10367900
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6315-20
references.pmid: 19325125
references.citation: Nature. 2006 Dec 21;444(7122):1083-7
references.pmid: 17183323
references.citation: Oncogene. 2005 Sep 22;24(42):6333-44
references.pmid: 15940249
references.citation: Cell Death Differ. 2011 Jul;18(7):1150-60
references.pmid: 20966964
references.citation: Nature. 2006 Dec 21;444(7122):1032-7
references.pmid: 17183313
references.citation: Nat Rev Cancer. 2003 Oct;3(10):756-67
references.pmid: 14570040
references.citation: J Virol. 1987 Jan;61(1):66-74
references.pmid: 3023708
references.citation: Am J Pathol. 1999 Mar;154(3):785-94
references.pmid: 10079256
references.citation: Cancer Cell. 2003 Jun;3(6):537-49
references.pmid: 12842083
references.citation: Clin Cancer Res. 2009 Apr 1;15(7):2291-301
references.pmid: 19258443
references.citation: Genes Dev. 2009 Aug 15;23(16):1882-94
references.pmid: 19608765
references.citation: Genes Cells. 1996 Jan;1(1):1-9
references.pmid: 9078362
references.citation: Nat Genet. 2000 Dec;26(4):484-9
references.pmid: 11101851
references.citation: Clin Cancer Res. 2009 Oct 15;15(20):6358-66
references.pmid: 19825954
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13909-14
references.pmid: 16172383
references.citation: Cancer Res. 2006 Mar 1;66(5):2778-84
references.pmid: 16510599
references.citation: Cancer Res. 2006 Jun 15;66(12):6312-8
references.pmid: 16778208
references.citation: Mol Cancer. 2009 Mar 02;8:12
references.pmid: 19254376
references.citation: J Mol Cell Cardiol. 2011 Sep;51(3):399-408
references.pmid: 21712044
references.citation: Neural Dev. 2010 Dec 01;5:31
references.pmid: 21122105
references.citation: FASEB J. 2007 Nov;21(13):3763-70
references.pmid: 17586727
references.citation: Cancer Res. 2007 Mar 1;67(5):1879-82
references.pmid: 17332312
references.citation: Mol Cell. 2000 Feb;5(2):197-206
references.pmid: 10882062
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6392-7
references.pmid: 18427106
references.citation: Nat Med. 2009 Aug;15(8):960-6
references.pmid: 19597504
references.citation: Genes Dev. 1998 Jun 15;12(12):1751-62
references.pmid: 9637676
references.citation: Nat Rev Mol Cell Biol. 2006 Sep;7(9):678-89
references.pmid: 16921404
references.citation: Cancer Res. 2005 Sep 15;65(18):8530-7
references.pmid: 16166334
references.citation: J Clin Invest. 2005 Nov;115(11):3166-76
references.pmid: 16239965
references.citation: Nature. 1995 Sep 28;377(6547):355-8
references.pmid: 7566092